SAN FRANCISCO, Sept. 10, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company developing novel drugs and biologics, today announced that it has been selected by the National Cancer Institute (NCI) as one of three contractors in response to the solicitation for the PREVENT Cancer Preclinical Drug Development

ROCKVILLE, Md., Sept. 10, 2019 /PRNewswire/ -- DrFirst, the nation's leading provider of e-prescribing, patient medication management, and price transparency solutions, announced today that its Backline s

ATLANTA, Sept. 10, 2019 /PRNewswire/ -- The American Cancer Society (ACS) celebrates its historic 35th anniversary of its signature fundraiser Relay For Life with the 2020 season kickoff. The Relay For Life movement is dedicated to uniting communities around the world to attack cancer from every angle. Since its inception in 1985, Relay For Life ha

TORONTO, Sept. 10, 2019 /PRNewswire/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, is pleased to share that its portfolio company Herbert Works Ltd. ("Herbert Works") has received its research and development (R&D) licence from Healt

BARCELONA, Spain, Sept. 10, 2019 /PRNewswire/ -- Note:  This is a summary of research presented this morning at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer. Click on the headline to view the complete news release.Lung cancer screening model favored in Europe detec

LIMA, Ohio, Sept. 10, 2019 /PRNewswire/ -- Today CORA Health Services, Inc., known as CORA Physical Therapy ("CORA"), a top-10 national operator of outpatient physical therapy services, announced nationwide relief efforts to assist in the aid of those impacted by Hurricane Dorian. CORA will be accepting donations at more than 200 clinic locations in nine states effective

NEW YORK, Sept. 10, 2019 /PRNewswire/ -- The Lasker Foundation today announced the winners of its 2019 Lasker Awards: Max D. Cooper from Emory University and Jacques Miller from the Walter and Eliza Hall Institute of Medical Research will receive the Albert Lasker

LEIDEN, Netherlands, Sept. 10, 2019 /PRNewswire/ -- Pharvaris B.V., a clinical-stage company focused on the discovery and development of novel oral B2-receptor antagonists for the treatme

DENVER, Sept. 10, 2019 /PRNewswire/ -- CereHealth Corporation through its subsidiary CereScan®, a national network of functional brain imaging and analytics centers, announced today that it has received approval of its Littleton, CO location as a qualified imaging facility for a Sun Pharma Advanced Research Company (SP

LUFKIN, Texas, Sept. 10, 2019 /PRNewswire/ -- Dr. Charles Evans with The Institute for Lifestyle, Preventive and Family Medicine is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called